tanshinone has been researched along with Multiple Sclerosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, C; Gu, H; Han, S; Li, D; Li, L; Li, Q; Li, S; Liu, M; Xu, G; Zheng, B | 1 |
| Gaire, BP; Subedi, L | 1 |
| Feng, J; Han, D; Yan, J; Yang, X | 1 |
1 review(s) available for tanshinone and Multiple Sclerosis
| Article | Year |
|---|---|
Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases.
Topics: Abietanes; Alzheimer Disease; Animals; Brain Ischemia; Humans; Multiple Sclerosis; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease | 2021 |
2 other study(ies) available for tanshinone and Multiple Sclerosis
| Article | Year |
|---|---|
Lipid Receptor G2A-Mediated Signal Pathway Plays a Critical Role in Inflammatory Response by Promoting Classical Macrophage Activation.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Abietanes; Animals; Antibodies, Neutralizing; Benzaldehydes; Case-Control Studies; Cell Cycle Proteins; Cell Polarity; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Knockout Techniques; Humans; Inflammation; Macrophage Activation; Macrophages; Male; Monocytes; Multiple Sclerosis; Oximes; Phospholipases A2, Secretory; Rats; Rats, Transgenic; Receptors, G-Protein-Coupled; Signal Transduction; Treatment Outcome | 2021 |
Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats.
Topics: Abietanes; Animals; Biomarkers; Brain; CD4 Antigens; CD8 Antigens; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression; Guinea Pigs; Immunohistochemistry; Immunosuppressive Agents; Interleukin-17; Interleukin-23; Macrophage-1 Antigen; Multiple Sclerosis; Rats | 2016 |